chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Strong Headache started 04/15/2021 around 6:30 pm. It went away on 04/21/2021. Headache came back on the following week when reading. Stop reading the headache go away after a while. Strong headache on 05/01/2021 after using computer. It did not go away. Went to sleep for 1 hour and the headache continued the rest of the day (not reading, no computer). Headache on 05/02/2021 since I woke up. NOTE: I never had a headache before.
Large localized reaction at vaccine administration site. Flushing and rash on chest. Treatment with BENADRYL - 2 office visits in Employee Health.
the patient came into the pharmacy stating he is having incompetent symptoms not sure if it's due the the moderna vaccine he received friday 4/16/2021.    He tried to have sex sunday 4/18 and monday 4/19 and seemed like he's having issue. He is stating he does not take medication and otherwise healthy. Not having any symptoms of incompetent before the vaccine.
only my arm hurt; tired; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: only my arm hurt) and tiredness (Verbatim: tired). The outcome of the pain in arm and tiredness were not reported.   It was unknown if the reporter considered the pain in arm and tiredness to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm and tiredness to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 04-JUL-2023 This case was reported by a patient via interactive digital media. The patient self reported the case. Only patient arm hurt and patient was tired next day, otherwise fine. The patient reported it was totally worth not getting shingles. The follow-up could not be possible as no contact details were available.
SWOLLEN LEFT ANKLE (DOUBLE IN SIZE); This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetic type 1 with insulin pump, alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the patient did not have any history of drug abuse or illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, Laboratory data included: Blood test (NR: not provided) Not reported, and Doppler ultrasound (NR: not provided) Not reported. On MAR-2021, the subject experienced swollen left ankle (double in size). On 15-MAR-2021, treatment medications included: furosemide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swollen left ankle (double in size). This report was non-serious.
Approximately a few hours after my 2nd dose vaccination, I experienced the following symptoms: Light fever, body aches, and chest pain (it was really painful to move and I felt like having a heart attack) I took Tylenol to help improve my situation. I went to an urgent care for consultation and I was advised to take ibuprofen and that helped with my chest pain. Up to this day I still have some episodes of chest pain.
Patient slumped over in wheel chair while waiting for a ride home a few minutes after receiving a Flulaval dose.  This patient has a history of frequent LOC in office before and after appointments.  She is greeted at the entrance with a wheel chair. Incident occurred at 10:00am and by 10:05 she was conversing with a provider. BP was 120/72 times 2, pulse 88 and 100, pulse ox 92 and 95, blood sugar 146.  Skin was warm and dry, color pale initially, then color improved quickly.  No respiratory difficulty. Diagnosed with pseudo syncopal episodes.  Was wheeled back to an exam room to be observed by a nurse and Dr. and discharged when her ride home arrived.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 61-year-old female patient who received SHINGRIX. Concomitant products included Lisinopril. On 14th April 2018, the patient received the 1st dose of SHINGRIX. In April 2018, several days after receiving SHINGRIX, the patient experienced rash, pustule and blister. On 28th April 2018, the patient experienced shingles, sensory disturbance and pain. On an unknown date, the outcome of the shingles was unknown and the outcome of the sensory disturbance and pain were recovering/resolving and the outcome of the rash, pustule and blister were not recovered/not resolved. It was unknown if the reporter considered the  shingles, rash, pustule and blister to be related to SHINGRIX. The reporter considered the sensory disturbance and pain to be related to SHINGRIX. Additional details were provided as follows: The reporter was the patient's son. Fourteen days after receiving SHINGRIX, the patient first experienced sensitivity on the lower right side of her back, pain and shingles. A few days later a rash appeared with pustule blisters. She sought medical treatment and her doctor diagnosed it as shingles. There was still evidence of the rash at the date of reporting.
Extreme pain at injection site within a few hours; fever, body aches, fatigue/malaise and chills within 24 hours and still ongoing; red, raised welt at injection site as of today, Wednesday, April 25 (3 days out).
patient had lupus before first dose of Shingrix but between doses there was an exacerbation; This case was reported by a pharmacist via call center representative and described the occurrence of systemic lupus erythematosus syndrome aggravated in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included systemic lupus erythematosus.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced systemic lupus erythematosus syndrome aggravated (serious criteria GSK medically significant). The patient was treated with prednisone. On an unknown date, the outcome of the systemic lupus erythematosus syndrome aggravated was unknown.   The reporter considered the systemic lupus erythematosus syndrome aggravated to be unrelated to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had lupus before 1st dose of Shingrix but between doses there was an exacerbation.  The health care provider asked for information regarding the administration of the 2nd dose of Shingrix. The reporter did not want to provide any details regarding the patient or the vaccine. The reporter consented for follow up.
Patient given Tdap as fourth dose rather than Dtap..no adverse reactions on date of vaccine or day 2 via follow up call
Client was vaccinated for Covid on 3/26 and 4/22/2021.  Was exposed to someone with Covid and was tested on 9/1 and 9/3.  PCR tests positive and client had no symptoms.  Reported as a case of breakthrough Covid in a fully vaccinated person.
Dizzy , diarrhea without stop , nauseous, gases, pain on my chest, have more than 3 days and it's worse.
Patient's arm was warm to touch, swollen, redness noted and she had some muscle pain. Dr. recommended ICE for treatment.
Pt appeared pale, c/o vertigo, skin was warm & moist. Parents stated she had a fall on way into observation room, but did not faint & had no c/o pain from fall. ROH WNL. BP 104/60, P 68 at 5:45pm. BP 102/68, P 68 at 5:53pm. Pt appeared to recover, was given cool liquids to drink & went home with parents.
admitted with COVID PNA requiring supplemental oxygen family reported altered mental status and cough pt started on decadron and remdesivir
tinnitus worsening from evening of 10/31/21 (both ears worse in left ear)
a patient received their first dose of Twinrix standard schedule in MAY-2022. The second dose was given on 27-MAY-2023.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 71-year-old female patient who received HAB (Twinrix) (batch number 2KE55, expiry date 22-SEP-2023) for prophylaxis.   Previously administered products included Twinrix (1st dose received in May 2022).   On 27-MAY-2023, the patient received the 2nd dose of Twinrix. On 27-MAY-2023, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: a patient received their first dose of Twinrix standard schedule in MAY-2022. The second dose was given on 27-MAY-2023.). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 31-MAY-2023 The reporter declined to provide initials.  The reporter did not consent to follow-up. The patient received 2nd dose of Twinrix, later than the recommended interval, which led to lengthening of vaccination schedule.
Pt reports redness/swelling at injection site day 0-3 after getting injection.  Reports all sx went away after day 3.  Reports day 6 after injection redness/swelling at injection site came back.  Site was also hot and itchy.  Initially started with a 2-3 inch diameter, but since day 6 it has spread to 4in by 5in today.  States site was never painful.  States color is slightly changing to less red starting today
On the first day, a little over 12 hours after the first vaccine, I felt light headed and was nauseous. By noon of that day I had a persistent migraine like headache that remained the entire day and into the next (3/21/2021).  On the 3/21/2021 I also experienced dull chest pain and a feeling of tightness throughout the entire day
First noticed itching on right calf, then swelling of leg and ankle, then dark spots that wouldn't go away. The first symptoms were shortly after the 3rd shot of the Gardasil series.
Two days after dose 2 Moderna vaccine (3-11-2022), I started having body pain/aches, fatigue, loss of appetite, fever up to 101 as well as bad swelling, redness, heat and firmness in my left arm below the vaccine site. The area was about "quarter size". I attempted to get an appointment to see the doctor the same day but no one ever called me back. I started taking OTC ibuprofen for the pain and swelling as well as a cool compress for the heat and redness on my arm. On 3-12, I noticed the redness started wrapping halfway around to the back of my arm. This lasted about 4 days. I am doing well now.
Patient was very nervous to have shots done per father. He held her hands when Vaccine BOOSTRIX was given in left arm/IM first with no reaction. Vaccine GARDASIL 9 was given in right arm/IM and as I put on half the band aid, the patient slumped her head forward as if she passed out. Then father and I laid her back and her eyes opened and she began to have a seizure. Father held her on her side as I ran and got Dr. Upon entering, the patient was coming out of it and had very pale skin. I pulled out the feel rest on the exam table. She was conscious and breathing and Dr. began to exam her and vital signs. Father stated that she had had this happen before with a blood draw. Patient has a history of seizures. She takes no medicine for it. Patient began to respond to father's voice and become aware of her surroundings again. Dr. asked me to get her some water and we sat her up and she drank and Dr. advised that she rest awhile. She laid back down for about 20 more minutes. Dr. and I checked her vital signs again and they were good and stable. Patient stated she wanted to go home and Father was comfortable taking her home so Dr. advised them they can leave but to call or come back if needed. I spoke with father today 7/31/18 and he stated patient is doing well and was a little sore for a couple days but had no other incidents and is doing fine. Protocols were followed per this facility.
The patient was scheduled for a 2nd Moderna primary vaccine at our clinic to complete his primary series; however, the nurse, gave the patient a Pfizer bivalent vaccine instead. The patient was called and informed of the error; he stated he had no side effects that day. The patient was called 2 days later for a follow-up and he stated he only had some swelling in the area but it went away. He stated he had no other side effects. The patient was not upset and understood the error.
1621 - Patient reported feeling dizzy and clammy.  Water was given, patient did not want to lay down at this time.  1627 - Continued to be clammy and dizzy, nausea but patient states "I'm not a puker".  Patient agreeable to laying on cot in clinic.  BP 148/82, HR 112, RR 23 and non labored.  1638 - Dizziness improving, no longer clammy.  BP 128/88, HR 104, RR 21, non labored.  1645 - Patient feeling better, went home from work to rest.
The patient had an injection on the right upper deltoid on Tuesday, 11/28/00, at 2 PM. On 11/29/00, swelling of the right arm, heavy, red, and painful. The client took Tylenol. On 11/30/00, her arm continued to be hot and itchy. On 12/01/00, she called to the office, then in to see the nurse. A telephone call was placed to her physician. The area is resolving.
This case was reported by a nurse and described the occurrence of swelling arm in a 5 year-old female subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. The nurse reported that "a number of" subjects experienced a reaction following receipt of the 5th dose of Infanrix, however, a specific number of subjects was not reported. On 02 May 2006, the subject received 5th dose of Infanrix in the left deltoid (lot AC14B021-incomplete lot number). The nurse reported that on 02 May 2006 after vaccination with "Infanrix-Tip-lock" the subject experienced "large local reaction to the vaccination" manifested by "swelling of the entire upper arm," injection site warmth and injection site redness. The area of swelling and erythema was five by ten inches over the injection site. The subject was treated with ibuprofen. The nurse considered that the events were possibly related to the use of Infanrix. The outcome of the events is unknown.
Per son and employee, patient's health had been declining since she was hospitalized for a severe UTI in Dec 2020. The evening of 02.09.2021 she vomited, then was found to be unresponsive the morning of 02.10.2021. Patient passed away later in the day on 02.10.2021.
Patient was here to receive 2nd dose pfizer to complete primary series.  Patient received the bivalent pfizer dose instead.  Patient is not experiencing any adverse effects and was told to contact us if that changed.
Shortness of breath; Chest pain; Chest discomfort; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Jun2021 (Lot number: EWO181) at the age of 23 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DYSPNOEA (non-serious) with onset 25Jun2021, outcome "recovered" (2021), described as "Shortness of breath"; CHEST PAIN (non-serious) with onset 25Jun2021, outcome "recovered" (2021), described as "Chest pain"; CHEST DISCOMFORT (non-serious) with onset 25Jun2021, outcome "recovered" (2021), described as "Chest discomfort". The events "shortness of breath", "chest pain" and "chest discomfort" were evaluated at the emergency room visit. Therapeutic measures were not taken as a result of dyspnoea, chest pain, chest discomfort.  Additional information:Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination.  No follow-up attempts are needed. No further information is expected.
Feeling cold; myalgia; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling cold) and MYALGIA (myalgia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING COLD (Feeling cold) and MYALGIA (myalgia). At the time of the report, FEELING COLD (Feeling cold) and MYALGIA (myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up document received
Received Hepatitis B vaccine in right arm.  Arm remains painful and some weakness noted at times.
pain at injection site followed after a few days with fever/burning sensation and malaise; complained of numbness in the area of injection; no clinical findings
Arm got a tad sore; makes her tired; Nausea; Chills; Hot flash; This is a spontaneous report from a contactable nurse via the Pfizer-sponsored program Pfizer First Connect. A 79-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unspecified route of administration on 13Jan2021 at a single dose for covid-19 immunization. Medical history included gastroparesis. Concomitant medication included estradiol, levothyroxine sodium (SYNTHROID), mirtazapine, calcium, colecalciferol (VITAMIN D). It was reported that the patient got the vaccine on the 13Jan2021. Wednesday and Thursday night, she was fine. On Friday (15Jan2021), she started getting nausea and chills. Then Saturday she was ok again. Then Sunday the nausea came back. She had had nausea since then. It comes in waves. When it is kind of mild, she doesn't feel so bad. This morning it has been bad. It makes her tired when the nausea gets like this. It may subside during the day. When she firsts get nausea, she gets hot flash. The patient's arm got a tad sore, but only a little. The outcome of the event chills was recovered on an unspecified date, nausea was not recovered while unknown for the other event.
Post second-vaccination, my menstrual period was much heavier, much more painful, and lasted longer than my 3-4 day average. The pain was barely treatable with ibuprofen, and taking that only took the pain from an 8 to a 6.
Congestion for 2 weeks, came to ER, Dx with bilateral PE's, started on Heparin drip, discharged home 11/20/21
Local pain, swelling, redness is expected and should; subside within the next 24-72 hrs. Advised may take Tylenol for pain, apply warm compresses to site and call back if any questions.
I was diagnosed with a respiratory infection that moved into my lungs and triggered my asthma. I made an appointment with my doctor; we discussed my symptoms. He ordered a chest x-ray to rule out pneumonia. Once the x-ray came back clear for pneumonia, I was given a prescription of prednisone to help with the inflammation of my lungs.
I had dizziness for a week after receiving my second Pfizer Covid-19 vaccine.
Information has been received from a nurse concerning a 25 year old female patient with no known drug reactions/allergies and medical history who on 07-JAN-2009 was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL (Lot #661530/0575X).  Concomitant therapy included LEVORA.  The nurse reported that the patient began vomiting 2.5 to 3 hours after administration the vaccine.  The patient vomited through that night and the next day.  The physician prescribed PHENERGAN for the patient which were effective in treating the symptom.  The patient sought medical attention by phone.  The patient recovered on 09-JAN-2009.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/13/2009. Follow up has been received from the nurse who reported that the patient completely recovered in 24 hours and she did not think the patient was willing to continue the vaccination series with GARDASIL. No additional was reported. Follow up has been received from the nurse who reported that the patient was vaccinated with her first dose in her right arm at 15:50 p.m. The patient had no pre-existing conditions or illness at the time of vaccination. The vomiting started at 18:00 p.m. The patient was prescribed promethazine 30 mg suppositories. No additional information was reported.
Pt. says he developed rashes in arm on Friday or Saturday and called physician and was advised BENADRYL. Now here for f/u rashes in abd & back - no DIB, SOB, but have allergies to multiple meds. It's unclear if the rashes is particularly to any of the shot per pt has not had reaction before. I have given him prednisone tapering dose, ZYRTEC and ZANTAC & f/u go to ER if SOB.
Systemic: heart racing, daughter said she has had panic attacks recently and this looked like that-Mild
Fever, chills, sweating, body aches, headache, nausea, vomiting.
A spontaneous report was received from a consumer, concerning a 72 year old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) where I passed out, hit my head and skull was bleeding, lost control of my body functions, sever chills, I could hardly move, threw up, extremely tired, don't feel good and  totally incoherent.  The patient's medical history was not provided by the reporter, concomitant medications are losartan, baby aspirin, pill for cholesterol included by the reporter.   On 05 Feb 2021, the patient received the first planned doses of mRNA-1273 on right arm and Lot number reported for the first dose was (010M20A) for prophylaxis of COVID-19 vaccination.  On 05 Mar 2021, the patient received the second  planned doses of mRNA-1273 on left arm and Lot number reported for the first dose was (014M20A) for prophylaxis of COVID-19 vaccination.   Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of I passed out, hit my head and skull was bleeding and lost control of my body functions were resolved and other events like sever chills, I could hardly move, threw up, extremely tired, don't feel good and  totally incoherent were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
RASH, eryth. papules on abd., paler red smaller papule innner thighs, faint eryth. on cheeks bilateral.
2hr p/vax high pitched inconsolable screaming-lasted 6hr hosp overnoc, t102.8;
Information has been received from a nurse concerning a 12 or 13 years old male patient, who on an unknown date, was vaccinated intramuscularly with a dose of GARDASIL (Lot number not reported). The health professional stated that the patient was using GARDASIL and experienced syncope with concussion. The patient went to the emergency room. The patient was given an unspecified treatment for the events. At the time of the report, patient was recovering. Additional information has been requested.
Red area extending from above knee to left hip and buttock area , no swelling . Given one dose of benadryl by parent and rash resolved in approx 2 hours.